The GST Council has reduced the tax rate on specific cancer drugs and helicopter travel on a ‘seat-share basis’ to 5%, while lowering the levy on namkeen from 18% to 12%. It also agreed to exempt R&D funded by private and public sources from GST. Discussions on health insurance tax reductions were deferred.
Related Posts
RBI imposes Rs 46 lakh penalty on three firms for non compliace
- staff
- February 21, 2025
- 0
The Reserve Bank of India (RBI) fined Citibank NA, JM Financial, and Asirvad Micro Finance for regulatory non-compliance. Citibank was penalized Rs 39 lakh for […]
Taiwan’s Delta Electronics plans to double Indian workforce, add 3000 employees in five years
Taiwan’s Delta Electronics is set to nearly double its Indian workforce from 3,500 to 6,500 employees over the next five years. The company has opened […]
Sebi removes 1% security deposit requirement for public issues
The Securities and Exchange Board of India (Sebi) has removed the 1% security deposit requirement for companies launching public equity share issues. This move aims […]